A combined synthetic-fibrin scaffold supports growth and cardiomyogenic commitment of human placental derived stem cells

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Lisi, Antonella ^a   Briganti, Enrica ^b   Ledda, Mario ^a   Losi, Paola ^b   Grimaldi, Settimio ^a   Marchese, Rodolfo ^c   Soldani, Giorgio ^b  

^a INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c S Peter Hospital FBF   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETICONE; FIBRIN; MESSENGER RNA; MOLECULAR SCAFFOLD; NITRIC OXIDE; POLYETHERURETHAN; TRANSCRIPTION FACTOR NKX2.5; TROPONIN I; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ACTIN; BAYSILON; POLYURETHAN; TISSUE SCAFFOLD; VIMENTIN;

AMNIOTIC MESENCHYMAL STROMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL METABOLISM; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; STROMA CELL; AMNION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; MESENCHYMAL STEM CELL; METABOLISM; PLACENTA; PREGNANCY; TISSUE ENGINEERING;

ACTINS; AMNION; CELL DIFFERENTIATION; CELL PROLIFERATION; DIMETHYLPOLYSILOXANES; FEMALE; FIBRIN; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STEM CELLS; MYOCARDIUM; NITRIC OXIDE; PLACENTA; POLYURETHANES; PREGNANCY; RNA, MESSENGER; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VIMENTIN;

EID: 84859255873     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034284     Document Type: Article

References (75)

1. Tang YL, Zhao Q, Zhang YC, Cheng L, Liu M, et al. (2004) Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 117 (1): 3-10.
2. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410 (6829): 701-705.
3. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, et al. (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 (12): 1210-1221.
4. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, et al. (2002) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106 (24): 3009-3017.
5. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, et al. (2006) Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355 (12): 1199-1209.
6. Freyman T, Polin G, Osman H, Crary J, Lu M, et al. (2006) A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27 (9): 1114-1122.
7. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, et al. (2003) Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution. Circulation 108 (7): 863-868.
8. Suuronen EJ, Kuraitis D, Ruel M, (2008) Improving cell engrafment with tissue engineering. Semin Thorac Cardiovasc Surg 20 (2): 110-114.
9. Xing Y, Lv A, Wang L, Yan X, Zhao W, et al. (2012) Engineered myocardial tissues constructed in vivo using cardiomyocyte-like cells derived from bone marrow mesenchymal stem cells in rats. J Biomed Sci 12;19: 6.
10. Simpson D, Liu H, Fan TH, Nerem R, Dudley SC, (2007) A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells 25 (9): 2350-2357.
11. Liu J, Hu Q, Wang Z, Xu C, Wang X, et al. (2004) Autologous stem cell transplantation for myocardial repair. Am J Physiol Heart Circ Physiol 287 (2): H501-511.
12. Xiong Q, Hill KL, Li Q, Suntharalingam P, Mansoor A, et al. (2011) A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling. Stem Cells 29 (2): 367-375.
13. Segers VFM, Lee RT, (2008) Stem-cell therapy for cardiac disease. Nature 451: 937-942.
14. Psaltis PJ, Zannettino AC, Worthley SG, Gronthos S, (2008) Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells 26: 2201-2210.
15. Parolini O, Alviano F, Bagnara GP, Bilic G, Buhring HJ, et al. (2008) Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26 (2): 300-311.
16. Parolini O, Soncini M, Evangelista M, Schmidt D, (2009) Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen Med 4 (2): 275-291.
17. Chang CJ, Yen ML, Chen YC, Chien CC, Huang HI, et al. (2006) Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells 24 (11): 2466-2477.
18. Wolbank S, Peterbauer A, Fahrner M, Hennerbichler S, van Griensven M, et al. (2007) Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13 (6): 1173-1183.
19. Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, et al. (2004) Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22 (7): 1338-1345.
20. Semenov OV, Koestenbauer S, Riegel M, Zech N, Zimmermann R, et al. (2010) Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of 'stemness' after isolation. Am J Obstet Gynecol 202 (2): 193.e1-193.e13.
21. Briganti E, Losi P, Raffi A, Scoccianti M, Munaò A, et al. (2006) Silicone based polyurethane materials: a promising biocompatible elastomeric formulation for cardiovascular applications. J Mater Sci Mater Med 17 (3): 259-266.
22. Briganti E, Spiller D, Mirtelli C, Kull S, Counoupas C, et al. (2010) A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenetic growth factors. J Control Release 142: 14-21.
23. Murry CE, Reinecke H, Pabon LM, (2006) Regeneration gaps: Observations on stem cells and cardiac repair. J Am Coll Cardiol 47 (9): 1777-1785.
24. Kraehenbuehl TP, Ferreira LS, Hayvward AM, Nahrendorf M, van der Vlies AJ, et al. (2011) Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials 32 (4): 1102-9.
25. Gu R, Bai J, Ling L, Ding L, Zhang N, et al. (2012) Increased Expression of Integrin-Linked Kinase Improves Cardiac Function and Decreases Mortality in Dilated Cardiomyopathy Model of Rats. PLoS One 7 (2): e31279.
26. Christman KL, Fok HH, Sievers RE, Fang Q, Lee RJ, (2004) Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng 10 (3-4): 403-409.
27. Kofidis T, de Bruin JL, Hoyt G, Ho Y, Tanaka M, et al. (2005) Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. J Heart Lung Transplant 24 (6): 737-744.
28. Kellar RS, Shepherd BR, Larson DF, Naughton GK, Williams SK, (2005) Cardiac patch constructed from human fibroblasts attenuates reduction in cardiac function after acute infarct. Tissue Eng 11 (11-12): 1678-1687.
29. Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, et al. (2000) Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 102 (19 suppl 3): III56-61.
30. Kofidis T, de Bruin JL, Hoyt G, Lebl DR, Tanaka M, et al. (2004) Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J Thorac Cardiovasc Surg 128: 571-578.
31. Miyagawa S, Sawa Y, Sakakida S, Taketani S, Kondoh H, et al. (2005) Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: Their integration with recipient myocardium. Transplantation 80: 1586-1595.
32. Zimmermann WH, Melnychenko I, Wasmeier G, Didié M, Naito H, et al. (2006) Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12: 452-458.
33. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, et al. (2006) Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12: 459-465.
34. Nakamuta JS, Danoviz ME, Marques FLN, dos Santos L, Becker C, et al. (2009) Cell Therapy Attenuates CardiacDysfunction Post Myocardial Infarction: Effect of Timing, Routes of Injection and a Fibrin Scaffold. PLoS ONE 4 (6): e6005.
35. Schmidt CE, Baier JM, (2000) A cellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 21 (22): 2215-2231.
36. Schaner PJ, Martin ND, Tulenko TN, Shapiro IM, Tarola NA, et al. (2004) Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg 40 (1): 146-153.
37. Itoh H, Aso Y, Furuse M, Noishiki Y, Miyata T, (2001) A honeycomb collagen carrier for cell culture as a tissue engineering scaffold. Artif Organs 25 (3): 213-217.
38. Berglund JD, Mohseni MM, Nerem RM, Sambanis A, (2003) A biological hybrid model for collagen-based tissue engineered vascular constructs. Biomaterials 24 (7): 1241-1254.
39. Niklason LE, Langer RS, (1997) Advances in tissue engineering of blood vessels and other tissues. Transpl Immunol 5 (4): 303-306.
40. Stock UA, Vacanti JP, (2001) Tissue engineering: current state and prospects. Annu Rev Med 52: 443-451.
41. Bensaid W, Triffitt JT, Blanchat C, Oudina K, Sedel L, et al. (2003) A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24 (14): 2497-2502.
42. Amrani DL, Diorio JP, Delmotte Y, (2001) Wound healing: role of commercial fibrin sealants. Ann NY Acad Sci 936: 566-579.
43. van Hinsbergh VW, Collen A, Koolwijk P, (2001) Role of fibrin matrix in angiogenesis. Ann NY Acad Sci 936: 426-437.
44. Fan CL, Gao PJ, Gu YJ, Tang XF, Liu JJ, et al. (2006) Therapeutic angiogenesis by intramuscular injection of fibrin particles into ischaemic hindlimbs. Clin Exp Pharmacol Physiol 33 (7): 617-622.
45. Ye Q, Zund G, Benedikt P, Jockenhoevel S, Hoerstrup SP, et al. (2000) Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 17 (5): 587-591.
46. Jockenhoevel S, Zund G, Hoerstrup SP, Chalabi K, Sachweh JS, et al. (2001) Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg 19 (4): 424-430.
47. van Amerongen MJ, Molema G, Plantinga J, Moorlag H, van Luyn MJ, (2002) Neovascularization and vascular markers in a foreign body reaction to subcutaneously implanted degradable biomaterial in mice. Angiogenesis 5 (3): 173-180.
48. Horii A, Wang X, Gelain F, Zhang S, (2007) Biological Designer Self-Assembling Peptide Nanofiber Scaffolds Significantly Enhance Osteoblast Proliferation, Differentiation and 3-D Migration. PLoS ONE 2 (2): e190.
49. Mangano C, Paino F, d'Aquino R, De Rosa A, Iezzi G, et al. (2011) Human Dental Pulp Stem Cells Hook into Biocoral Scaffold Forming an Engineered Biocomplex. PLoS ONE 6 (4): e18721.
50. Polini A, Pisignano D, Parodi M, Quarto R, Scaglione S, (2011) Osteoinduction of Human Mesenchymal Stem Cells by Bioactive Composite Scaffolds without Supplemental Osteogenic Growth Factors. PLoS ONE 6 (10): e26211.
51. Cebotari S, Mertsching H, Kallenbach K, Kostin S, Repin O, et al. (2002) Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 106: I63-I68.
52. Soldani G, Briganti E, (2010) A method for producing a device applicable to biological tissues, particularly a patch for treating damaged tissues, and a device obtained by said method. PCT/IB2010/052343, 2010.
53. Soldani G, Bernabei M, Losi P, Crucean A, Chiappino D, et al. (2004) In vitro experiments and in vivo implants to evaluate a new silicone-based polyurethane material for replacement of small vessels. Cardiol Young 14 (suppl3): 20-23.
54. Losi P, Briganti E, Magera A, Spiller D, Ristori C, et al. (2010) Tissue response to poly(ether)urethane-polydimethylsiloxane-fibrin composite scaffolds for controlled delivery of pro-angiogenic growth factors. Biomaterials 31 (20): 5336-5344.
55. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, et al. (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9 (9): 1195-1201.
56. Kinnaird T, Stabile E, Burnett MS, Epstein SE, (2004) Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ Res 95 (4): 354-363.
57. Caplan AI, Dennis JE, (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98 (5): 1076-1084.
58. Manuelpillai U, Moodley Y, Borlongan CV, Parolini O, (2011) Amniotic membrane and amniotic cells: potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta 32 (Suppl 4): S320-5.
59. Kanno S, Kim PK, Sallam K, Lei J, Billiar TR, et al. (2004) Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proc Natl Acad Sci USA 101 (33): 12277-12281.
60. Feng Q, Song W, Lu X, Hamilton JA, Lei M, et al. (2002) Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation 106 (7): 873-879.
61. Bloch W, Fleischmann BK, Lorke DE, Andressen C, Hops B, et al. (1999) Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc Res 43 (3): 675-684.
62. Gupta MK, Walthall JM, Venkataraman R, Crowder SW, Jung DK, et al. (2011) Combinatorial polymer electrospun matrices promote physiologically-relevant cardiomyogenic stem cell differentiation. PLoS One 6 (12): e28935.
63. Burattini S, Ferri P, Battistelli M, Curci R, Luchetti F, et al. (2004) C2C12 murine myoblasts as a model of skeletal muscle development morpho-functional characterization. Euro J Histochem 48 (3): 223-233.
64. Sanger JW, Chowrashi P, Shaner NC, Spalthoff S, Wang J, et al. (2002) Myofibrillogenesis in skeletal muscle cells. Clin Orthop Relat Res 403 (Suppl): S153-162.
65. Rodríguez JP, González M, Ríos S, Cambiazo V, (2004) Cytoskeletal organization of human mesenchymal stem cells (MSC) changes during their osteogenic differentiation. J Cell Biochemistry 93 (4): 721-731.
66. Yourek G, Hussain MA, Mao JJ, (2007) Cytoskeletal changes of mesenchymal stem cells during differentiation. ASAIO J 53 (2): 219-228.
67. Wang N, Naruse K, Stamenovic D, Fredberg JJ, Mijailovich SM, et al. (2001) Mechanical behavior in living cells consistent with the tensegrety model. Proc Natl Acad Sci USA 98 (14): 7765-7770.
68. Lim CT, Zhou EH, Quek ST, (2006) Mechanical models for living cells a review. J Biomech 39 (2): 195-216.
69. Titushkin I, Cho M, (2007) Modulation of cellular mechanics during osteogenic differentiation of human mesenchymal stem cells. Biophys J 93 (10): 3693-3702.
70. Lian N, Wang W, Li L, Elefteriou F, Yang X, (2009) Vimentin inhibits ATF4-mediated osteocalcin transcription and osteoblast differentiation. J Biol Chem 284 (44): 30518-30525.
71. Katare RG, Ando M, Kakinuma Y, Sato T, (2010) Engineered heart tissue: a novel tool to study the ischemic changes of the heart in vitro. PLoS One 17;5 (2): e9275.
72. Casey ML, MacDonald PC, (1996) Interstitial collagen synthesis and processing in human amnion: A property of the mesenchymal cells. Biol Reprod 55: 1253-1260.
73. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284 (5411): 143-147.
74. Lee RH, Kim B, Choi I, Kim H, Choi HS, et al. (2004) Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14 (4-6): 311-324.
75. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (4): 402-408.